English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/144117
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Characterization of ferritin 2 for the control of tick infestations

AuthorsHajdušek, Ondřej; Almazán, Consuelo; Villar, Margarita ; Canales, Mario ; Grubhoffer, Libor; Kopáček, Petr; Fuente, José de la
KeywordsFerritin
Vaccine
Tick
Iron metabolism
RNA interference
Boophilus
Ixodes
Issue Date2010
PublisherElsevier
CitationVaccine 28(17): 2993-2998 (2010)
AbstractIxodes ricinus is one the most abundant tick species in Europe and these ticks transmit pathogens causing human and animal diseases. The cattle ticks, Rhipicephalus (Boophilus) spp., affect cattle production in tropical and subtropical regions of the world. Development of vaccines directed against tick proteins may reduce tick infestations and the transmission of tick-borne pathogens. However, a limiting step in tick vaccine development has been the identification of tick protective antigens. Herein, the tick iron metabolism pathway was targeted in an effort to identify new tick protective antigens. Recombinant I. ricinus (IrFER2) and Rhipicephalus microplus (RmFER2) ferritin 2 proteins were expressed in Escherichia coli and used to immunize rabbits and cattle, respectively. Vaccination with IrFER2 reduced I. ricinus tick numbers, weight and fertility in rabbits with an overall vaccine efficacy (E) of 98%. Control of cattle tick, R. microplus and Rhipicephalus annulatus infestations was obtained in vaccinated cattle with overall E of 64% and 72%, respectively. Notably, the efficacy of the RmFER2 vaccine was similar to that obtained with Bm86 against R. microplus. These collective results demonstrated the feasibility of using ferritin 2 to develop vaccines for the control of tick infestations.
URIhttp://hdl.handle.net/10261/144117
DOI10.1016/j.vaccine.2010.02.008
Identifiersdoi: 10.1016/j.vaccine.2010.02.008
issn: 0264-410X
e-issn: 1873-2518
Appears in Collections:(IREC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.